Protein-protein interaction maps provide a valuable framework for a better understanding of the functional organization of the proteome. To detect interacting pairs of human proteins systematically, a protein matrix of 4456 baits and 5632 preys was screened by automated yeast two-hybrid (Y2H) interaction mating. We identified 3186 mostly novel interactions among 1705 proteins, resulting in a large, highly connected network. Independent pull-down and coimmunoprecipitation assays validated the overall quality of the Y2H interactions. Using topological and GO criteria, a scoring system was developed to define 911 high-confidence interactions among 401 proteins. Furthermore, the network was searched for interactions linking uncharacterized gene products and human disease proteins to regulatory cellular pathways. Two novel Axin-1 interactions were validated experimentally, characterizing ANP32A and CRMP1 as modulators of Wnt signaling. Systematic human protein interaction screens can lead to a more comprehensive understanding of protein function and cellular processes.
Introduction
Protein-protein interactions (PPIs) are crucial for all biological processes. Therefore, compiling PPI networks provides many new insights into protein function. Also, interaction networks are relevant from a systems biology point of view, as they may help to uncover the generic organization principles of functional cellular networks, when both spatial and temporal aspects of interactions are considered (Ge et al., 2003) . The gener-*Correspondence: erich.w@mdc-berlin.de ation of accurate cellular protein interaction networks is an ongoing process, in which data produced by highthroughput yeast two-hybrid screens (Y2H) and mass spectroscopy contribute in a complementary manner (Bork et al., 2004) .
The Y2H system is a powerful tool for the identification of PPIs, which can be applied in high-throughput manner to detect interactions across the entire proteome of an organism. Proteome-wide studies for model organisms such as H. pylori ( , we have carried out a matrix interaction mating screen. This approach yields reproducible interaction data without the necessity of repeated sequencing, once a bait/prey protein matrix is established. We have systematically screened more than 5500 human proteins for potential interactions, building an interaction network that connects 1705 human proteins via 3186 interactions. The quality of the dataset was validated by independent biochemical interaction assays and bioinformatic analyses. Furthermore, we have evaluated the network to identify proteins potentially involved in human regulatory pathways and have characterized experimentally two novel modulators of the Wnt signaling cascade. The network presented here can be regarded as a starting point for the construction of a 
Results

Construction of a Human Y2H PPI Map
For the identification of interactions by a Y2H matrix approach ( Figure 1A) , a nonredundant set of cDNAs was obtained from the sequence analysis of a human fetal brain expression library (Bussow et al., 1998) . We generated 3510 bait and 3589 prey clones by subcloning of cDNA fragments into DNA binding domain (DBD) and activation domain (AD) Y2H vectors, respectively. In addition, a "GATEWAY recombinational cloning" approach was used to shuttle full-length human open reading frames (ORFs) from entry vectors into Y2H plasmids, yielding further 2033 bait and 2051 prey clones.
From the total of 11,183 Y2H clones, we created a matrix for systematic interaction mating. A MATα yeast strain was individually transformed with the 5640 prey plasmids, and 5543 bait plasmids were introduced into a MATa strain. For interaction screening, eight clones expressing non-self-activating baits were pooled and mated with the prey clones. Positive clones, which activated the HIS3 and URA3 reporter, were identified by growth on selective plates ( Figure 1B ) and/or lacZ reporter gene activation in β-galactosidase assays. All positive preys identified in the first pooled mating screens were individually retested for interactions with each of the eight baits in a second mating assay ( Figure  1C ). An unambiguously positive interaction was only assigned to a pair of proteins after two independent mating assays. More than 25 million protein pairs (4456 baits × 5632 preys) were examined, and 3269 interactions among 1064 baits and 1075 preys were identified ( Figure 1A and see Tables S1-S3 in the Supplemental Data available with this article online) . The Y2H interactions were grouped into two data sets: those that activated all three reporter genes, HIS3, URA3, and lacZ (LacZ4 set), and those that activated only the two growth reporters HIS3 and URA3 (SD4 set). The LacZ4 and SD4 sets comprise 2124 and 1145 interactions, respectively.
To examine whether the protein matrix is an unbiased representation of the human proteome, gene ontology (GO) criteria were applied (Ashburner et al., 2000) . Except for membrane proteins, which were underrepresented because the library used for subcloning was selected for cDNAs that encode proteins without transmembrane domains, similar size fractions of proteins annotated to the different GO component as well as GO function categories ( Figure 1D, upper and lower panel) . Interestingly, the distribution of proteins in both the GO function and component classes remained largely the same among the identified interactions as in the matrix and the complete proteome ( Figure 1D , inner circles). In Figure 1E , the protein length distribution of the matrix and the interacting proteins was compared with all human ORFs encoded in the genome. In all three groups, the majority of proteins had a predicted length between 100 and 500 amino acids.
Experimental Verification of Interactions
To evaluate the quality of the Y2H data, a representative sample of interactions was randomly selected for verification assays because interactions recapitulated independently are unlikely to be experimental false positives (Goehler et al., 2004) . Using a membrane coimmunoprecipitation assay (Figure 2A) , 116 protein pairs were tested with a success rate of 72/116 (62%). Another 131 interactions were verified in pull-down experiments (Figure 2B) , with a success rate of 87/131 (66%). With both assays, a difference in success rates was observed when the SD4 (56%) and the LacZ4 data (67%) were compared (chi-square p = 0.11). These results demonstrate that our Y2H data contain a large fraction of interactions that can be confirmed by other methods. They also support previous Y2H studies , emphasizing the difference in validity of the interactions from the SD4 and the LacZ4 sets.
Properties of the Y2H Network
For analysis of the protein interaction data, each cDNA was mapped to an NCBI gene locus (Table S2) . After collapsing 83 interactions that occurred in bait/prey and prey/bait configurations or that mapped pairwise to the same gene loci, a total of 3186 unique interactions between 1705 different human proteins was obtained (Tables S1 and S3 ). Computational analysis of the data revealed one giant network of 3131 interactions between 1613 proteins and 43 small isolated networks of less than six proteins ( Figure S2 ). For the large interaction network, a mean shortest path length between any two proteins of 4.85 links was calculated ( Figure 3A ). This means that most proteins are very closely linked, a phenomenon that has been described as small world property of networks (Strogatz, 2001 ).
Next, we calculated the degree distribution P(k) of the human proteins, measuring the probability that a The Reporter Gene Activation Criterion Y2H interactions that can be identified by activation of three reporter genes are of higher confidence and can be reproduced with higher success rates than interac- 
Identification of High-Confidence Interactions
To classify Y2H interactions into categories of low, medium, and high confidence, an interaction was awarded one quality point for each fulfilled criterion described above. 5749 points were given to 2618 of the 3186 PPIs, with any given interaction receiving between 0 and 6 quality points. Interactions were then ranked according to their number of quality points and grouped into the three confidence sets ( Figure 4C ). Five hundred sixtyeight (18%) Y2H interactions did not receive quality points and were classified as of low confidence (LC set). 1707 interactions (54%) obtained 1-2 quality points and were classified as of medium confidence (MC set). (Table S8) . Importantly, the data allowed the definition of 911 highconfidence interactions that collected 3 or more quality points (HC set, 28%), involving 401 different human proteins.
Finally, we determined whether the assignment of Y2H interactions into confidence sets is statistically significant. We quantified the numbers of Y2H interactions in the confidence sets and compared the results with the numbers obtained for interactions from randomized networks. As shown in Figure 4D , Y2H interactions were found with higher frequency in the HC set (3 or more quality points) than interactions from random networks. This indicates that our scoring system for the selection of interactions with potential higher biological relevance yields statistically significant results.
Properties of the High-Confidence PPI Network
The group of HC interactions resulting from our confidence-scoring procedure mainly contains interactions with biological context information, i.e., interactions where additional supportive information, like GO coannotation or participation in loop motifs, is available. Therefore, we suggest that the HC interactions are most promising with regard to further functional analysis and the generation of new hypotheses. Because of this increased relevance, we specially extracted a network of the HC interactions from our data, which is charted in Figure 5A . We grouped the proteins in three broad categories using GO and OMIM criteria: disease proteins (45), uncharacterized proteins (49), and known proteins (307). For the 45 disease proteins, 163 HC PPIs were identified (Table S1 ). This information can be used as a resource for disease-specific investigations.
As visible in Figure 5A , the majority of proteins (87%) are linked and form a large interaction network. In addition, 24 small networks with less than six proteins were obtained. The proteins contained in the HC set are still a nonbiased representation of the human proteome when GO criteria are applied ( Figure S5 that the mean path length between proteins is significantly shorter and the average clustering coefficient is higher in the HC map ( Figure S5 ). These results suggest that the HC network has an even more pronounced hierarchical structure than the complete network and contains a larger number of closely linked protein clusters, which could be indicative of functional protein complexes (Barabasi and Oltvai, 2004 ).
Development of a Database for Network Exploration
Accompanying this manuscript, a web-based searchable database was created at http://www.mdc-berlin. de/neuroprot/database.htm. This database permits queries for protein names and synonyms, accession numbers, gene names, and official gene symbols, as well as LocusLinkID. Annotations are provided for every protein and every interaction it is involved in. The database also enables a graphical representation of queried proteins and their interaction partners. Links to bibliographic references and relevant external databases are also included. A screen-shot illustration of the user interface is presented in the Supplemental Data. Table S4 for a survey). We found that these proteins had 568 interactions in the Y2H network, 168 of which were HC. They link 115 proteins, including 13 disease proteins, to the 22 different regulatory pathways. Eight proteins, e.g., (ZHX1, PTN, EEF1A1, ANP32A, CRMP1, GTF3C1, UNC119, and KIAA1377) were found to connect via HC interactions with proteins in the Wnt signaling pathway (Figure 5B ), which controls patterning and organogenesis during development and is important for tumor formation in adults (Logan and Nusse, 2004) .
Linking Y2H Interactions to Regulatory Pathways
A direct comparison between the Y2H network and 22 human regulatory pathways from the Kyoto encyclopedia of genes and genomes-KEGG (Kanehisa et al., 2004)-revealed that the two data sets share 162 proteins involved in different signal transduction processes or neurodegenerative diseases (see
Using bioinformatic tools, we also identified proteins that form links with two or more proteins annotated in a KEGG pathway, increasing the confidence of the pathway assignment. This approach identified 66 proteins, including seven disease proteins (Table S5) , 2001 ). In the assay, moderate overexpression of Dvl in HEK293 cells caused a 4-fold increase in reporter gene activity. However, this increase was reduced to 1.5-fold in a dose-dependent manner, when full-length ANP32A or CRMP1 were coexpressed ( Figure 6C ). The activity of protein fragments in the Wnt signaling assay correlated with their ability to bind Axin-1. The C-terminal half of ANP32A containing the Axin-1 binding site was sufficient to suppress Wnt signaling, while the N-terminal 150 amino acids of ANP32A were inactive. Similarly, the C-terminal fragment of CRMP1 containing the Axin-1 binding site reduced Lef/Tcf-dependent transcription as efficiently as the full-length protein, while the N-terminal part had no effect ( Figure 6C ). These results demonstrate that connecting proteins via Y2H interactions to signaling cascades such as the Wnt pathway allows the identification of potential pathway modulators.
Discussion
To assign functions to uncharacterized proteins and to understand the composition of protein complexes, several large-and medium-scale interaction studies have been undertaken using the Y2H system or MS-based functional proteomics approaches ( Here, we report a first systematic Y2H analysis of human proteins. Using a matrix approach and two rounds of automated interaction mating, we identified 3186 in- 
recently attempted to explain that the low coverage of interaction data sets is to be expected without assuming false positives, because currently available methods are only capable of producing incomplete data sets. We suggest that novel identification as well as multiple-step validation/confirmation strategies will have to be put in place in order to produce comprehensive, crossconnected interaction data sets.
To identify interactions that are biologically meaningful, a confidence-scoring system was developed using experimental, topological, and GO criteria (Figure 4) . Protein clusters were detected significantly more often in the Y2H network than in any of the random control networks, indicating that biologically relevant, functional complexes can be recognized in the interaction data (Supplemental Data). For example, we identified new interaction partners for the disease protein emerin (EMD), which causes X-linked Emery-Dreifuss muscular dystrophy (EDMD) when mutated (Emery, 2002) . Emerin binds to the Src-homology 3 proteins SH3GL2 and SH3GL3 and the uncharacterized developmental pluripotency-associated protein 4 (DPPA4), which itself binds to SH3GL3 and SH3GL1, thus forming a small, highly connected interaction cluster. The identification of these interactions might promote understanding of EMD function in mammalian cells and can be used as a starting point for investigating the role of the participating proteins in EDMD pathogenesis.
Another interesting outcome of our study is the high connectedness of network proteins to proteins of gene regulatory pathways listed in the KEGG database. Using simple bioinformatic tools, we directly linked about 150 human proteins via HC interactions to the 22 different KEGG pathways. In addition, proteins that bridge two or more proteins in a given pathway were identified. Utilizing this more stringent approach, 66 proteins could be newly mapped to one or more KEGG pathways (Tables S4 and S5 ). Using cell-based assays, we functionally validated two of the proteins, which were linked to the Wnt pathway by computational analysis (Figure 6 ). We found that the proteins ANP32A and CRMP1, which are both implicated in disease processes (Bai et al., 2001; Shih et al., 2003) , can suppress canonical Wnt signaling, suggesting that they might be functional modulators of this pathway in vivo. This indicates that Y2H screening combined with bioinformatic pathway mapping increases our knowledge about signaling cascades and permits design of new experimental strategies.
Conclusions
This report supplies more than 3000 protein-protein interactions, 911 supported with topological and GO criteria, 159 verified biochemically. The interaction map links 195 disease proteins to previously unidentified partners, allows the description of 342 uncharacterized human proteins via their interactions, and suggests new roles for hundreds of known proteins. Also, the study integrates Y2H interaction data with known regulatory pathways, extracting potential functional modules that participate in signaling cascades from the static, large-scale human Y2H map. This human PPI map will serve as a unique resource for further experimentation and analysis leading to the identification of disease-modifier genes and new drug targets.
Experimental Procedures
Subcloning of Human cDNAs into Y2H Plasmids 9665 cDNAs of the hEx1 library (Bussow et al., 1998) were sequenced from the 5# end to determine the identity and the reading frame of each cDNA fragment. BLASTP analysis against the nr (NCBI) or TrEMBL (Swiss-Prot) databases revealed a nonredundant set of 4275 cDNAs, which were inserted by restriction cloning into the Y2H plasmids pGAD426 and pBTM117c (http://www.mdc-berlin. de/neuroprot/labequip.htm). For recombinational cloning of human full-length ORFs, 2136 human cDNA fragments were PCR amplified with specific primer pairs from source clones of the RZPD repository and BP cloned into pDONR201 (Invitrogen, Carlsbad). Recombinant clones were sequenced and annotated using BLASTP searches. cDNA fragments were then shuttled into the Y2H vectors pBTM116-D9 and pGAD426-D3 by recombinational cloning (http:// www.rzpd.de/products/orfclones/). The redundancy of clones in the matrix, i.e., clones coding for different parts of the same proteins, was less than 4%. In total, 48% of the plasmids encoded fulllength ORFs, whereas 52% coded for C-terminal fragments of larger human proteins.
Automated Y2H Screening
To create a matrix for interaction mating, the L40ccα MATα yeast strain (Goehler et al., 2004 ) was individually transformed with prey plasmids (coding Gal4 activation domain fusions); the resulting yeast clones were arrayed in 384-well microtiter plates. Simultaneously, the bait plasmids (coding LexA DNA binding domain fusions) were introduced into a L40ccU MATa strain and assembled in 96-well plates. Baits (19.6%), which activated the HIS3, URA3, and lacZ reporter genes after mating with a MATα strain expressing an AD protein, were excluded from the automated Y2H analysis.
For interaction mating, 5 l liquid cultures of the MATα yeast strains were replicated in 384-well MTPs using a pipetting robot (Biomek FX), grown, and mixed with 40 l pooled MATa strains (eight baits). The yeast mixtures were then transferred onto YPD agar plates using a spotting robot (KBiosystems) and incubated for 36 hr at 30°C. After mating, the clones were automatically picked from the plates and transferred into 384-well MTPs containing SDII (-Leu-Trp) liquid medium. For selection of PPIs, diploid yeasts were spotted onto SDIV (-Leu-Trp-Ura-His) agar plates as well as nylon membranes placed on SDIV agar plates. After 5-6 days of incubation at 30°C, digitized images of the agar plates and nylon membranes were assessed for growth and β-galactosidase activity using the software Visual Grid (GPC Biotech).
For confirmation of interactions, the eight baits from each pool were arrayed in 96-well MTPs (Biomek 2000) and mated with the positive preys identified in the first mating screen. After 36 hr at 30°C, yeast cultures were spotted onto SDII agar plates for selection of diploid cells expressing both protein fusions. After 4 days at 30°C, the yeast colonies were assayed on SDIV agar plates and nylon membranes. 
Membrane Coimmunopurification and Pull-Down Assays
